Northern Trust Corp Raises Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Northern Trust Corp raised its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 11.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,591,776 shares of the company’s stock after buying an additional 166,731 shares during the quarter. Northern Trust Corp owned approximately 0.42% of LifeStance Health Group worth $11,731,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. lifted its stake in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after buying an additional 2,122 shares during the last quarter. R Squared Ltd purchased a new stake in LifeStance Health Group in the fourth quarter valued at approximately $80,000. Cibc World Markets Corp purchased a new stake in LifeStance Health Group in the fourth quarter valued at approximately $96,000. Forum Financial Management LP acquired a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $110,000. Finally, Handelsbanken Fonder AB acquired a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $128,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Trading Up 0.9%

Shares of LFST stock opened at $5.84 on Friday. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The stock has a market cap of $2.27 billion, a P/E ratio of -22.46 and a beta of 1.30. The business has a fifty day simple moving average of $6.53 and a 200-day simple moving average of $7.21. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

Insider Activity

In related news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now owns 339,810 shares of the company’s stock, valued at $2,344,689. This trade represents a 5.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on LFST shares. KeyCorp began coverage on LifeStance Health Group in a report on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 target price on the stock. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Finally, Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $8.30.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.